Serge H. Boyer

1.9k total citations
28 papers, 1.2k citations indexed

About

Serge H. Boyer is a scholar working on Organic Chemistry, Molecular Biology and Pharmacology. According to data from OpenAlex, Serge H. Boyer has authored 28 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Organic Chemistry, 10 papers in Molecular Biology and 9 papers in Pharmacology. Recurrent topics in Serge H. Boyer's work include Carbohydrate Chemistry and Synthesis (7 papers), Microbial Natural Products and Biosynthesis (7 papers) and Synthetic Organic Chemistry Methods (6 papers). Serge H. Boyer is often cited by papers focused on Carbohydrate Chemistry and Synthesis (7 papers), Microbial Natural Products and Biosynthesis (7 papers) and Synthetic Organic Chemistry Methods (6 papers). Serge H. Boyer collaborates with scholars based in United States and Germany. Serge H. Boyer's co-authors include Samuel J. Danishefsky, Mark D. Erion, Paul D. van Poelje, K. Raja Reddy, Steven H. Olson, James M. Fujitaki, Jorge Gomez‐Galeno, Margaret Y. Chu‐Moyer, Stephen A. Hitchcock and David L. Linemeyer and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Hepatology.

In The Last Decade

Serge H. Boyer

28 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Serge H. Boyer United States 18 473 424 245 214 202 28 1.2k
Xiao‐Wu Chen China 16 575 1.2× 115 0.3× 186 0.8× 210 1.0× 90 0.4× 32 1.1k
Olaf Kinzel Italy 17 389 0.8× 255 0.6× 203 0.8× 122 0.6× 37 0.2× 42 964
Sheng Tang China 17 379 0.8× 237 0.6× 90 0.4× 71 0.3× 27 0.1× 43 752
Jan S. Kramer Germany 13 211 0.4× 118 0.3× 71 0.3× 38 0.2× 42 0.2× 32 530
Vincent Leroux France 15 253 0.5× 311 0.7× 61 0.2× 67 0.3× 75 0.4× 29 856
Hongjiang Xu China 15 373 0.8× 192 0.5× 58 0.2× 27 0.1× 89 0.4× 41 773
David D. Anderson United States 16 266 0.6× 320 0.8× 47 0.2× 183 0.9× 28 0.1× 26 771
Chang‐Hyun Oh South Korea 26 850 1.8× 1.3k 3.1× 38 0.2× 44 0.2× 34 0.2× 109 1.9k
Sangmi Oh South Korea 17 429 0.9× 397 0.9× 97 0.4× 98 0.5× 32 0.2× 42 868
Fisayo A. Olotu South Africa 18 439 0.9× 160 0.4× 103 0.4× 144 0.7× 23 0.1× 79 857

Countries citing papers authored by Serge H. Boyer

Since Specialization
Citations

This map shows the geographic impact of Serge H. Boyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Serge H. Boyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Serge H. Boyer more than expected).

Fields of papers citing papers by Serge H. Boyer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Serge H. Boyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Serge H. Boyer. The network helps show where Serge H. Boyer may publish in the future.

Co-authorship network of co-authors of Serge H. Boyer

This figure shows the co-authorship network connecting the top 25 collaborators of Serge H. Boyer. A scholar is included among the top collaborators of Serge H. Boyer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Serge H. Boyer. Serge H. Boyer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Reddy, K. Raja, Jonathan Parkinson, Mojgan Sabet, et al.. (2021). Selection of QPX7831, an Orally Bioavailable Prodrug of Boronic Acid β-Lactamase Inhibitor QPX7728. Journal of Medicinal Chemistry. 64(23). 17523–17529. 16 indexed citations
2.
Breen, C., Changfeng Huang, Serge H. Boyer, et al.. (2020). Scalable On-Demand Production of Purified Diazomethane Suitable for Sensitive Catalytic Reactions. Organic Process Research & Development. 25(3). 522–528. 10 indexed citations
3.
Hecker, Scott J., K. Raja Reddy, Olga Lomovskaya, et al.. (2020). Discovery of Cyclic Boronic Acid QPX7728, an Ultrabroad-Spectrum Inhibitor of Serine and Metallo-β-lactamases. Journal of Medicinal Chemistry. 63(14). 7491–7507. 158 indexed citations
4.
Gomez‐Galeno, Jorge, Qun Dang, Serge H. Boyer, et al.. (2010). A Potent and Selective AMPK Activator That Inhibits de Novo Lipogenesis. ACS Medicinal Chemistry Letters. 1(9). 478–482. 75 indexed citations
5.
MacKenna, Deidre A., Annika C. Montag, Serge H. Boyer, David L. Linemeyer, & Mark D. Erion. (2009). Delivery of high levels of anti-proliferative nucleoside triphosphates to CYP3A-expressing cells as a potential treatment for hepatocellular carcinoma. Cancer Chemotherapy and Pharmacology. 64(5). 981–991. 6 indexed citations
6.
Reddy, K. Raja, Michael C. Matelich, Bheemarao G. Ugarkar, et al.. (2008). Pradefovir: A Prodrug That Targets Adefovir to the Liver for the Treatment of Hepatitis B. Journal of Medicinal Chemistry. 51(3). 666–676. 55 indexed citations
7.
Boyer, Serge H., Hongjian Jiang, Jason Jacintho, et al.. (2008). Synthesis and Biological Evaluation of a Series of Liver-Selective Phosphonic Acid Thyroid Hormone Receptor Agonists and Their Prodrugs. Journal of Medicinal Chemistry. 51(22). 7075–7093. 45 indexed citations
8.
Hecker, Scott J., K. Raja Reddy, Paul D. van Poelje, et al.. (2007). Liver-Targeted Prodrugs of 2‘-C-Methyladenosine for Therapy of Hepatitis C Virus Infection. Journal of Medicinal Chemistry. 50(16). 3891–3896. 29 indexed citations
9.
Boyer, Serge H., Zhili Sun, Hongjian Jiang, et al.. (2006). Synthesis and Characterization of a Novel Liver-Targeted Prodrug of Cytosine-1-β-d-arabinofuranoside Monophosphate for the Treatment of Hepatocellular Carcinoma. Journal of Medicinal Chemistry. 49(26). 7711–7720. 37 indexed citations
10.
Boyer, Serge H., Bheemarao G. Ugarkar, Michael C. Matelich, et al.. (2005). Adenosine Kinase Inhibitors. 5. Synthesis, Enzyme Inhibition, and Analgesic Activity of Diaryl-erythro-furanosyltubercidin Analogues. Journal of Medicinal Chemistry. 48(20). 6430–6441. 32 indexed citations
11.
Boyer, Serge H., Bheemarao G. Ugarkar, & Mark D. Erion. (2003). Stereoselective synthesis of 4-C-methyl-2,3,5-tri-O-benzyl-d-ribofuranose and 4-C-methyl-2,3,5-tri-O-benzyl-l-lyxofuranose. Tetrahedron Letters. 44(21). 4109–4112. 1 indexed citations
12.
Sissi, Claudia, et al.. (1999). Interaction of calicheamicin γ 1 I and its related carbohydrates with DNA–protein complexes. Proceedings of the National Academy of Sciences. 96(19). 10643–10648. 14 indexed citations
13.
Depew, Kristopher M., Serge H. Boyer, Derek J. Denhart, et al.. (1996). Synthese und DNA‐Bindungseigenschaften von Hybriden aus der Kohlenhydrat‐Einheit von Calicheamicin γ1I und den Aglycon von Daunorubicin: Calichearubicine A und B. Angewandte Chemie. 108(23-24). 2972–2975. 9 indexed citations
14.
Halcomb, Randall L., Serge H. Boyer, Mark D. Wittman, et al.. (1995). Studies Related to the Carbohydrate Sectors of Esperamicin and Calicheamicin: Definition of the Stability Limits of the Esperamicin Domain and Fashioning of a Glycosyl Donor from the Calicheamicin Domain. Journal of the American Chemical Society. 117(21). 5720–5749. 49 indexed citations
15.
Hitchcock, Stephen A., Margaret Y. Chu‐Moyer, Serge H. Boyer, Steven H. Olson, & Samuel J. Danishefsky. (1995). A Remarkable Glycosidation Reaction: The Total Synthesis of Calicheamicin .gamma.1I. Journal of the American Chemical Society. 117(21). 5750–5756. 50 indexed citations
16.
Hitchcock, Stephen A., Serge H. Boyer, Margaret Y. Chu‐Moyer, Steven H. Olson, & Samuel J. Danishefsky. (1994). ChemInform Abstract: A Convergent Total Synthesis of Calicheamicin γI 1.. ChemInform. 25(33). 1 indexed citations
17.
Hitchcock, Stephen A., Serge H. Boyer, Margaret Y. Chu‐Moyer, Steven H. Olson, & Samuel J. Danishefsky. (1994). Eine konvergente Totalsynthese von Calicheamicin γI1. Angewandte Chemie. 106(8). 928–931. 21 indexed citations
18.
Hitchcock, Stephen A., Serge H. Boyer, Margaret Y. Chu‐Moyer, Steven H. Olson, & Samuel J. Danishefsky. (1994). A Convergent Total Synthesis of Calicheamicin γ. Angewandte Chemie International Edition in English. 33(8). 858–862. 59 indexed citations
19.
Halcomb, Randall L., Serge H. Boyer, & Samuel J. Danishefsky. (1992). Synthese des Aryltetrasaccharidteilstücks von Calicheamicin mit reduzierendem Terminus: Verknüpfung des vollsynthetischen Aglycons und des Kohlenhydratteils durch die Schmidt‐Reaktion. Angewandte Chemie. 104(3). 314–317. 16 indexed citations
20.
Boyer, Serge H. & Dennis R. Petersen. (1991). Hepatic biochemical changes as a result of acute cocaine administration in the mouse. Hepatology. 14(6). 1209–1216. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026